DEFA14AThe Ballot
LIGAND PHARMACEUTICALS INC files DEFA14A
Filed Apr 21, 2026 · 2mo ago · Accession 0000886163-26-000022
Plain English
This supplemental filing for Ligand Pharmaceuticals Incorporated (Ligand) provides updated information regarding its 2026 Annual Meeting of Stockholders. The primary purpose is to inform shareholders about a change in the meeting date and to provide additional details related to the proposals being voted on.
Filing details
- Company
- LIGAND PHARMACEUTICALS INC
- Ticker
- LGND
- CIK
- 886163
- Form type
- DEFA14A
- Filing date
- Apr 21, 2026
- Report date
- —
- Document
- ligand-2026proxysupplement.htm
- Size
- 623 KB